APA (7th ed.) Citation

JK, B., RL, B., I, G., SH, Y., JR, S., & MD, C. (2011). Absence of novel CYP4F2 and VKORC1 coding region DNA variants in patients requiring high warfarin doses. Clinical medicine & research, 9(3-4), 119. https://doi.org/10.3121/cmr.2011.951

Chicago Style (17th ed.) Citation

JK, Burmester, Berg RL, Glurich I, Yale SH, Schmelzer JR, and Caldwell MD. "Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses." Clinical Medicine & Research 9, no. 3-4 (2011): 119. https://doi.org/10.3121/cmr.2011.951.

MLA (9th ed.) Citation

JK, Burmester, et al. "Absence of Novel CYP4F2 and VKORC1 Coding Region DNA Variants in Patients Requiring High Warfarin Doses." Clinical Medicine & Research, vol. 9, no. 3-4, 2011, p. 119, https://doi.org/10.3121/cmr.2011.951.